NIH VideoCast - Demystifying Medicine - Encephalitis and the Immune System

Skip Navigation

Demystifying Medicine - Encephalitis and the Immune System

Loading... Loading video...

281 Views

Air date:	Tuesday, February 11, 2020, 4:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 281 (84 Live, 197 On-demand)
Category:	Demystifying Medicine
Runtime:	01:20:21
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Demystifying Medicine Lecture Series Encephalitis, the inflammation of the brain, can be brought on by viral, bacterial and fungal infections, autoimmune diseases, and immunosuppression. Many diseases causing encephalitis are transmitted by mosquitos and ticks. As such, encephalitis is sadly pervasive, affecting more than 4 million people annually worldwide and causing upwards of 150,000 deaths. Symptoms range from mild headaches and nausea to debilitating seizures, hallucinations, and difficulty speaking and remembering. The patient volunteers at the NIH Clinical Center, many of whom are immunocompromised, are at a heightened risk for encephalitis. Immunotherapies and other treatments raise the risk even higher. Nath, clinical director at the National Institute of Neurological Disorders and Stroke, and Smith, a staff clinician in the NINDS Section of Infections of the Nervous System, are at the front lines in protecting these patients while they are on NIH protocols. For more information go to https://demystifyingmedicine.od.nih.gov

NLM Title:	Demystifying medicine. Encephalitis and the immune system / Avindra Nath, Bryan Smith.
Author:	Nath, Avindra. Smith, Bryan. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): Encephalitis, the inflammation of the brain, can be brought on by viral, bacterial and fungal infections, autoimmune diseases, and immunosuppression. Many diseases causing encephalitis are transmitted by mosquitos and ticks. As such, encephalitis is sadly pervasive, affecting more than 4 million people annually worldwide and causing upwards of 150,000 deaths. Symptoms range from mild headaches and nausea to debilitating seizures, hallucinations, and difficulty speaking and remembering. The patient volunteers at the NIH Clinical Center, many of whom are immunocompromised, are at a heightened risk for encephalitis. Immunotherapies and other treatments raise the risk even higher. Nath, clinical director at the National Institute of Neurological Disorders and Stroke, and Smith, a staff clinician in the NINDS Section of Infections of the Nervous System, are at the front lines in protecting these patients while they are on NIH protocols.
Subjects:	Encephalitis Viruses--pathogenicity Encephalitis, Viral--immunology Immunocompromised Host--immunology
Publication Types:	Lecture Webcast

NLM Classification:	WC 540
NLM ID:	101763747
CIT Live ID:	35580
Permanent link:	https://videocast.nih.gov/watch=35580

Related Videos...